ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

News

In The News ADVI director Lindsay Bealor Greenleaf talks changes to drug rebates and PBMs with the Washington Post
In The News ADVI CEO Marc Samuels On FDA Commissioner Gottlieb’s Comments Related to CAR-T Label Change
In The News Lindsay Bealor Greenleaf discusses the NDPC’s new pharmacy benefit contracting model with Managed Healthcare Executive
In The News Lindsay Bealor Greenleaf Discusses the Top Healthcare Takeaways from the Midterm Elections with Managed Healthcare Executive
In The News Lindsay Bealor Greenleaf discusses the administration’s proposed Part B drug model with Fierce Healthcare
In The News Lindsay Bealor Greenleaf discusses the administration’s Part B drug International Pricing Index model with Fierce Healthcare
In The News Lindsay Bealor Greenleaf talks to HealthLeaders Media about the pitfalls of requiring list price disclosure in TV ads
In The News Lindsay Bealor Greenleaf talks to Fierce Healthcare about PhRMA’s plan for DTC ads to direct patients to online resources about a drug’s cost and available financial assistance
In The News Lindsay Bealor Greenleaf speaks with Fierce Healthcare about the impact of the newly-enacted pharmacy gag clause laws

Posts pagination

< Previous page 1 … 19 20 21 … 25 Next page >
© 2025
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health